BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28965629)

  • 21. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.
    Beltzung F; Ortonne N; Pelletier L; Beylot-Barry M; Ingen-Housz-Oro S; Franck F; Pereira B; Godfraind C; Delfau MH; D'Incan M; Vergier B
    Am J Surg Pathol; 2020 Jul; 44(7):862-872. PubMed ID: 32271188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline.
    Toberer F; Hartschuh W; Hadaschik E
    JAMA Dermatol; 2013 Aug; 149(8):956-9. PubMed ID: 23760549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
    Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
    Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature.
    James E; Sokhn JG; Gibson JF; Carlson K; Subtil A; Girardi M; Wilson LD; Foss F
    Leuk Lymphoma; 2015 Apr; 56(4):951-7. PubMed ID: 24996443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior.
    Grogg KL; Jung S; Erickson LA; McClure RF; Dogan A
    Mod Pathol; 2008 Jun; 21(6):708-15. PubMed ID: 18311111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological analysis of primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoproliferative disorder: a retrospective study of 22 patients.
    Shi HZ; Zhang J; Xiong JS; Gan L; Jiang YQ; Xu XL; Zhang W; Zeng XS; Sun JF; Chen H
    Int J Dermatol; 2021 Apr; 60(4):497-502. PubMed ID: 33369742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.
    Rodríguez Pinilla SM; Roncador G; Rodríguez-Peralto JL; Mollejo M; García JF; Montes-Moreno S; Camacho FI; Ortiz P; Limeres-González MA; Torres A; Campo E; Navarro-Conde P; Piris MA
    Am J Surg Pathol; 2009 Jan; 33(1):81-90. PubMed ID: 18987541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4
    Oschlies I; Kock K; Wüseke T; Richter J; Koch K; Wehkamp U; Klapper W
    Histopathology; 2023 Feb; 82(3):485-494. PubMed ID: 36341542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.
    Battistella M; Beylot-Barry M; Bachelez H; Rivet J; Vergier B; Bagot M
    Arch Dermatol; 2012 Jul; 148(7):832-9. PubMed ID: 22508770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
    Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
    Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
    J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
    Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
    Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases.
    Leinweber B; Beltraminelli H; Kerl H; Cerroni L
    Dermatology; 2009; 219(1):42-7. PubMed ID: 19349695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal.
    Noe MH; Drake A; Link BK; Liu V
    J Cutan Pathol; 2013 Aug; 40(8):714-9. PubMed ID: 23651057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma With Expression of Follicular T-Helper Cell Markers and Spontaneous Remission.
    Ayala D; Ramón MD; Cabezas M; Jordá E
    Actas Dermosifiliogr; 2016 May; 107(4):357-9. PubMed ID: 26724830
    [No Abstract]   [Full Text] [Related]  

  • 37. Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma.
    Khamaysi Z; Ben-Arieh Y; Epelbaum R; Bergman R
    Am J Dermatopathol; 2006 Oct; 28(5):434-7. PubMed ID: 17012921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
    Martires KJ; Ra S; Abdulla F; Cassarino DS
    Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
    Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
    Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.